Clinical trials

  • [AL[18F]F]FAPI-74 for Carcinoma of Unknown Primary
  • everolimus for Metastatic breast cancer | Estrogen receptor-positive breast cancer | HER2-negative breast cancer
  • ABBV-319 for Follicular lymphoma|Chronic lymphocytic leukemia|Diffuse large B-cell lymphoma|B-cell malignancies
  • ACALABRUTINIB for Chronic lymphocytic leukemia (CLL) | Small lymphocytic lymphoma (SLL) | Relapsed chronic lymphocytic leukemia
  • Fluticasone propionate; Salbutamol sulfate for Asthma
  • SACITUZUMAB TIRUMOTECAN for Gastric adenocarcinoma | Gastroesophageal junction adenocarcinoma | Esophageal adenocarcinoma
  • BELUMOSUDIL MESILATE for Chronic graft versus host disease
  • CANNABIDIOL for Breast cancer (early, hormone receptor-positive) | Aromatase inhibitor-associated musculoskeletal pain
  • BOMEDEMSTAT for Essential thrombocythemia
  • Cannabidiol for Early breast cancer | Hormone receptor-positive breast cancer
  • SONLICROMANOL for Primary mitochondrial disease (m.3243A>G) | MELAS | MIDD
  • DEXRAZOXANE for Diffuse large B-cell lymphoma (DLBCL)